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1. Introduction 
Tay-Sachs disease is characterized by an accumula- 
tion of two types of glycosphingolipids, on the one 
hand ganglioside GM? (GalNAc-&1,4-(NeuNAc-&2,3) 
-Gal+1,4-Glc_13-1,1{2-N-acyl) sphingosine), and on 
the other its asialo residue (GalNAc-/3-1,4-Gal_P1,4- 
GlcQ- 1,1(2-N-acyl)sphingosine) in nerve tissue [ l-31 . 
The disease is assumed to involve a lack of the enzyme 
which catabolizes the stored substances, similar to 
that present in other sphingolipidoses [4,5]. In a 
special case of Tay-Sachs disease with visceral storage 
of kidney globoside (GalNAc-P_1,3-Gal-/3-1,4-Gal-&l,4 
GlcQ-1 ,l (2-N-acyl)sphingosine) a general lack of /3-N- 
acetylhexosaminidase activity was found [6] (fig. Id). 
The stored glycosphingolipids (ganglioside GM, and 
its asialo residue in nerve tissue, and kidney globoside 
in the visceral organs) in this case had in common a 
terminal /3-glycosidic-bound N-acetylgalactosamine, 
being partially hydrolized by PN-acetylhexosamini- 
dase-preparations [6,7]. The same substances also 
accumulate in the various tissues of conventional 
Tay-Sachs cases, although the storage level of the 
asialo residue of ganglioside GM, and of the kidney 
globoside is found to be lower [6]. Accordingly, the 
lack of some particular /3-N-acetylhexosaminidase was 
discussed as one of the possible causes for storage in 
cases of conventional Tay-Sachs disease [6]. In the 
present study the f3-N-acetylhexosaminidase pattern 
of 4 cases of conventional Tay-Sachs disease is des 
cribed. In three of the four cases a lack of the PN-ace- 
Abbreviations used: Gal, D-galactose; GalNAc, N-acetyl-D- 
galactosamine; Glc, D-glucose; NeuNAc, N-acetylneuraminic 
acid. 
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tyl hexosaminidase fraction with an isoelectric point at 
pH 5 was found. Okada and O’Brien* have obtained 
similar results with basically different methods. 
2. Materials and methods 
2.1. Materials 
Postmortal tissue of children 2 to 3 years of age 
was frozen several hours after death and stored at 
-20” until examinlrtion took place. The diagnosis of 
all the conventional Tay-Sachs cases including the 
variant without any demonstrable &N-acetylhexosami- 
nidase deficiency, was confirmed by the level of storage 
of glycosphingolipids in nerve tissue (quantitative 
evaluation according to ref. IS]). Ganglioside GM* 
constituted 12-18% of the total, whereas its asialo 
residue made up 3-6% of the total lipid extract. The 
special Tay-Sachs case where visceral storage of kidney 
globoside was found has already been described else- 
where [6] . 
2.2. Preparation of the /3-N-acetylhexosaminidases 
and their separation by isoelectric focusing 
The /?-N-acetylhexosaminidases were prepared 
from 50 g brain tissue according to Frohwein and Gatt 
[9] and fractionated by isoelectric focusing using the 
method of Vesterberg and Svensson [ 131, as described 
earlier [lo] . Convection-free electrolysis of a mixture 
of carrier ampholytes (LKB-Producter AB, Stockholm- 
Bromma, Sweden) in an appropriate electrolysis column 
* Presented at the Gordon Conference, July 1969, personal 
communication, and manuscript submitted for publication. 
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Q. 1. Variation ofp-N-acetylhexosaminidase pattern in the brain tissue of cases with Tay-Sachs disease. a) Normal human pattern; 
b) Unaltered pattern in a conventional Tay-Sachs case; c) Partially defective pattern in a conventional Tay-Sachs case; d) Defective 
pattern in the special Tay-Sachs case with visceral storage of kidney globoside [ 61. Curves were obtained by isoelectric focusing as 
described in section 2. - p-N-Acetylhexosaminidase activity measured at 410 nm:-o---o-o-o Extinction at 280 mn; . . . . pfi 
values. 
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gives a stable pH gradient, in which the multiple PN- 
acetylhexosaminidases can be focused at their res- 
pective isoelectric points [ 141 . A mixture containing 
50 1.11 of each fraction taken from the electrolysis 
column, 1 ~Mol pnitrophenyl-N-acetyl+D-glucosa- 
minide and 950 ~10.1 m citrate-phosphate buffer 
(pH 4.5; 10m3 M EDTA) was incubated for 30 min 
at a temperature of 37”. The incubated mixture 
was then processed according to Findlay et al. [ 1 l] , 
whereby the amount of the liberated p-nitrophenol 
was determined at a wavelength of 410 nm. 
3. Results and discussion 
Fig. la demonstrates the normal human brain 
pattern of /.?-N-acetylhexosaminidases of children 
2 to 3 years of age. The two main enzyme fractions 
have their isoelectric points at pH 7.3 and 5, respecti- 
vely [lo] . The analogous P-N-acetylhexosaminidase 
pattern of the special case of Tay-Sachs disease with 
visceral storage of kidney globoside is shown in fig. Id. 
A total lack of both /3-N-acetylhexosaminidase 
fractions was found. Fig. lc shows a partial lack of 
/3-N-acetylhexosaminidase activity in brain tissue 
from a case of conventional Tay-Sachs disease. The 
P-N-acetylhexosaminidase fraction with its isoelectric 
point at pH 5 is completely absent. Rather than the 
expected enzyme fraction, a very large amount of 
enzymatic inactive material was found (fig. 1 c). This 
enzyme defect, however, could not be established in 
brain tissue of a further case of conventional Tay- 
Sachs disease (fig. lb). Here, the pattern of O-N-acetyl- 
hexosaminidases appeared to be normal qualitatively, 
though not quantitatively. All remaining enzyme 
fractions of these two conventional Tay-Sachs cases 
showed P-N-acetylglucosaminidase as well as /I-N-acetyl- 
galactosaminidase activity and hydrolyzed the asialo 
residue of ganglioside GM*. 
More recently, the occurrence of two additional 
cases of conventional Tay-Sachs disease enabled us to 
confirm the lack of the /?-N-acetylhexosaminidase 
fraction with an isoelectric point at pH 5 in liver and 
brain, similar to the case presented in fig. 1 c. The en- 
zyme fraction with an isoelectric point at pH 7.3 
showed a 3- to 4-fold increase over normal activity in 
brain tissue of all the conventional Tay-Sachs cases 
hitherto studied (fig. lb,c and both additional cases). 
Since the deficiency of the enzyme fraction with an 
isoelectric point at pH 5 does not appear in one of the 
cases of conventional Tay-Sachs disease cited above 
(fig. lb), the relationship between this enzyme defect 
and the storage of glycosphingolipids still remains an 
open question. According to an investigation of puri- 
fied enzyme preparations as yet unpublished, both 
fi-N-acetylhexosaminidase fractions have a very similar 
substrate specificity. A possible genetic connection 
might be suspected, since both enzyme fractions were 
lacking in the tissues of the particular case of Tay-Sachs 
disease with visceral storage of kidney globoside. Both 
enzyme fractions have been localized in the lysosomes 
by studies performed with human spleen tissue [12]. 
Further studies will have to elucidate to which extent 
the two fractions of ,3-N-acetylhexosaminidase - despite 
of their apparent similarities - have separate physio- 
logical functions. 
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